Do Italian small cell lung cancer (SCLC) specialists share a common language? An analysis based on 549 questionnaires.
Different specialists are involved in the treatment of SCLC: medical oncologists, pneumologists, radiotherapists, and thoracic surgeons; only in large institutions the therapeutic policy is the result of a multidisciplinary approach. In order to investigate the opinions of the Italian physicians about the state of the art in the diagnosis and treatment of SCLC, 2369 questionnaires have been sent to an equal number of specialists. Each questionnaire contained 16 topics addressing what we consider major open questions. The analysis is based on 549 interpretable questionnaires received back (23.1%). The general attitude of responding physicians is quite pessimistic on the present state of the art; the large majority considering insufficient the current knowledge of both clinical and basic research. Some differences have been registered, among different specialists, regarding the role of surgery and radiation therapy in prolonging the expected survival; while a nearly unanimous consensus has been reached on the role of radiation therapy for local control. Optimism merges about the possibilities of ameliorating the survival in the next decades: 48% have confidence in new drugs, 45% in the development of integrated modalities, and 41% in the application of basic research.
Rosti
G
G
Division di Oncologia Medica, Ospedale S. Maria delle Croci, Ravenna, Italy.
Meacci
M
M
Nanni
O
O
Albertazzi
L
L
Zumaglini
F
F
Vertogen
B
B
Marangolo
M
M
D000328:Adult; D018288:Carcinoma, Small Cell; D006801:Humans; D007558:Italy; D008175:Lung Neoplasms; D008495:Medical Oncology; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires; D009626:Terminology as Topic